108 related articles for article (PubMed ID: 16268490)
1. Identification of the novel signal peptide mutation, antithrombin-Siriraj causes type-I antithrombin deficiency in thai patients.
Chinthammitr Y; Chinchang W; Ruchutrakool T; Viprakasit V
Thromb Haemost; 2005 Sep; 94(3):678-9. PubMed ID: 16268490
[No Abstract] [Full Text] [Related]
2. A novel mutation in the antithrombin gene (insT 7429-30) causes superior mesenteric vein thrombosis.
Bagnobianchi A; Ordóñez A; Miñano A; Sánchez I; Cano H; Del Rey ML; Hernández-Espinosa D; González-Conejero R; Corral J
Thromb Res; 2007; 119(6):793-6. PubMed ID: 16839598
[No Abstract] [Full Text] [Related]
3. Identification of six novel mutations in type I antithrombin deficient Italian families.
Di Perna P; Vecchione G; D'Andrea G; Scenna G; Brancaccio V; Margaglione M
Haematologica; 2004 Jan; 89(1):117-8. PubMed ID: 14754620
[No Abstract] [Full Text] [Related]
4. [Type I antithrombin deficiency due to 13389G deletion in antithrombin gene].
Fu Q; Xu X; Ding Q; Hu Y; Wang X; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):588-90. PubMed ID: 12482344
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of antithrombin deficiency in two Chinese families. One novel and one recurrent point mutation in the antithrombin gene causing venous thrombosis.
Zhou RF; Fu QH; Wang WB; Xie S; Dai J; Ding QL; Wang XF; Wang HL; Wang ZY
Thromb Haemost; 2005 Dec; 94(6):1172-6. PubMed ID: 16411389
[TBL] [Abstract][Full Text] [Related]
6. Intracerebral hemorrhage associated with a novel antithrombin gene mutation in a neonate.
Baud O; Picard V; Durand P; Duchemin J; Proulle V; Alhenc-Gelas M; Devictor D; Dreyfus M
J Pediatr; 2001 Nov; 139(5):741-3. PubMed ID: 11713457
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin niigata: a novel missense mutation (Thr194-Ile) of the antithrombin gene results in type I deficiency.
Fuse I; Ozawa T; Higuchi W; Aizawa Y
Thromb Haemost; 2000 Dec; 84(6):1126. PubMed ID: 11154130
[No Abstract] [Full Text] [Related]
8. Creation of an additional glycosylation site as a mechanism for type I antithrombin deficiency.
Fitches AC; Lewandowski K; Olds RJ
Thromb Haemost; 2001 Oct; 86(4):1023-7. PubMed ID: 11686319
[TBL] [Abstract][Full Text] [Related]
9. [A novel mutation in antithrombin gene results in hereditary antithrombin deficiency].
Zhang FH; Ding QL; Wu JS; Zhou RF; Wang XF; Xu XC
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):598-601. PubMed ID: 17278425
[TBL] [Abstract][Full Text] [Related]
10. [A heterozygous point mutation G13328A in antithrombin gene causes thrombosis].
Zhou RF; Shi GC; Fu QH; Wang WB; Xie S; Dai J; Ding QL; Hu YQ; Wang XF; Deng WW; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):661-4. PubMed ID: 16620552
[TBL] [Abstract][Full Text] [Related]
11. Laboratory approach in Thai patients with venous thrombosis.
Arnutti P; Nathalang O; Prayoonwiwat W; Lumkul R; Pulket C
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S116-20. PubMed ID: 16858949
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.
Tiede A; Tait RC; Shaffer DW; Baudo F; Boneu B; Dempfle CE; Horellou MH; Klamroth R; Lazarchick J; Mumford AD; Schulman S; Shiach C; Bonfiglio LJ; Frieling JT; Conard J; von Depka M
Thromb Haemost; 2008 Mar; 99(3):616-22. PubMed ID: 18327412
[TBL] [Abstract][Full Text] [Related]
13. Factors with conformational effects on haemostatic serpins: implications in thrombosis.
Hernández-Espinosa D; Ordóñez A; Vicente V; Corral J
Thromb Haemost; 2007 Sep; 98(3):557-63. PubMed ID: 17849043
[TBL] [Abstract][Full Text] [Related]
14. [Type I hereditary antithrombin deficiency due to C2757T heterozygotic mutation in antithrombin gene].
Zhou RF; Dai Q; Fu QH; Wang WB; Xue S; Ding QL; Hu YQ; Wang XF; Wang HL
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1640-2. PubMed ID: 16185535
[No Abstract] [Full Text] [Related]
15. Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis.
Chowdhury V; Lane DA; Mille B; Auberger K; Gandenberger-Bachem S; Pabinger I; Olds RJ; Thein SL
Thromb Haemost; 1994 Aug; 72(2):198-202. PubMed ID: 7831651
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosis.
Barba P; Santamaría A; Tirado I; Martí E; Fontcuberta J
Thromb Haemost; 2008 Feb; 99(2):443-4. PubMed ID: 18278198
[No Abstract] [Full Text] [Related]
17. Hereditary basis of protein C deficiency (PCD) in thrombosis patients: first report from India.
Pai N; Shetty S; Idicula-Thomas S; Kulkarni B; Ghosh K
Thromb Haemost; 2009 Apr; 101(4):785-7. PubMed ID: 19350130
[No Abstract] [Full Text] [Related]
18. Antithrombin Morioka (Cys 95-Arg): a novel missense mutation causing type I antithrombin deficiency.
Ozawa T; Takikawa Y; Niiya K; Fujiwara T; Suzuki K; Sato S; Sakuragawa N
Thromb Haemost; 1997 Feb; 77(2):403. PubMed ID: 9157604
[No Abstract] [Full Text] [Related]
19. [Homozygous antithrombin type HBS deficiency; a family study].
Guermazi S; Elloumi-ZghaL H; Ben Hassine L; Romani S; Khalfallah N; Abdelhak S; Dellagi K
Pathol Biol (Paris); 2007 Jun; 55(5):256-61. PubMed ID: 17140748
[TBL] [Abstract][Full Text] [Related]
20. Genetic risk factors for venous thrombosis.
Spek CA; Reitsma PH
Mol Genet Metab; 2000; 71(1-2):51-61. PubMed ID: 11001795
[No Abstract] [Full Text] [Related]
[Next] [New Search]
